Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      With USFDA approval in Hand, Esperion to launch Non-Statin Cholesterol drug NEXLETOL  for as low as 10 dollars

      With USFDA approval in Hand, Esperion to launch Non-Statin Cholesterol drug NEXLETOL for as low as 10 dollars

      Medical Dialogues Bureau22 Feb 2020 4:10 PM IST
      Eligible patients in the USA with commercial drug insurance coverage for NEXLETOL may pay as little as $10 per fill, up to a 3-month supply.
      Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit

      Top Cos in pharmaceutical supply chain develop Blockchain system to track prescription drugs, stop counterfeit

      Medical Dialogues Bureau22 Feb 2020 4:04 PM IST
      Among the 24 participating companies are Amgen Inc, FedEx Corp, GlaxoSmithKline Plc, Novartis, AmerisourceBergen Corp , Sanofi ), Walgreens Boots...
      Eli Lilly Completes Acquisition of Dermira

      Eli Lilly Completes Acquisition of Dermira

      Medical Dialogues Bureau22 Feb 2020 9:45 AM IST
      INDIANAPOLIS : Eli Lilly and Company has announced the successful completion of its acquisition of Dermira, Inc. (NASDAQ: DERM). The acquisition...
      ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak

      ICRA revises domestic pharma industry outlook to negative due to coronavirus outbreak

      Medical Dialogues Bureau21 Feb 2020 12:22 PM IST
      According to Icra research, domestic API manufacturers have an inventory of one-two months, which should adequately support their production till...
      Serum Institute to come up with coronavirus vaccine by 2022

      Serum Institute to come up with coronavirus vaccine by 2022

      Medical Dialogues Bureau21 Feb 2020 12:13 PM IST
      The vaccine candidate, developed by SII in partnership with American biotechnology firm Codagenix, has progressed to the pre-clinical test phase (the...
      Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs

      Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs

      Medical Dialogues Bureau21 Feb 2020 11:58 AM IST
      The meeting was attended by Biocon's Kiran Mazumdar Shaw, Zydus' Pankaj Patel and Dr Reddy's Laboratories' Satish Reddy and other top pharma execs
      Anglo-French co Novacyt  launches CE-IVD Marked novel coronavirus diagnostics test

      Anglo-French co Novacyt launches CE-IVD Marked novel coronavirus diagnostics test

      Medical Dialogues Bureau20 Feb 2020 3:16 PM IST
      Paris, France and Camberley: Novacyt an international specialist in clinical diagnostics recently announced that its molecular diagnostics...
      FDA grants priority review to Roches Tecentriq monotherapy as first-line treatment in certain lung cancer cases

      FDA grants priority review to Roche's Tecentriq monotherapy as first-line treatment in certain lung cancer cases

      Medical Dialogues Bureau20 Feb 2020 2:20 PM IST
      Basel: Roche announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and...
      Primary healthcare can play key role in combating outbreaks like coronavirus: Biocon Chief Kiran Mazumdar-Shaw

      Primary healthcare can play key role in combating outbreaks like coronavirus: Biocon Chief Kiran Mazumdar-Shaw

      Medical Dialogues Bureau20 Feb 2020 2:17 PM IST
      New Delhi: Biocon Chairperson and MD Kiran Mazumdar-Shaw on Wednesday stressed the need for having an effective primary healthcare system saying it...
      WuXi Biologics Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

      WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader

      Medical Dialogues Bureau20 Feb 2020 9:15 AM IST
      Shanghai: WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...
      China offers tariff exemptions on US medical equipment amid virus outbreak

      China offers tariff exemptions on US medical equipment amid virus outbreak

      Medical Dialogues Bureau19 Feb 2020 3:43 PM IST
      Beijing: China will waive trade-war tariffs on imports of selected US medical equipment from March 2, the government said Tuesday, as the country...
      Abbott introduces next-generation heart rhythm management devices in Europe

      Abbott introduces next-generation heart rhythm management devices in Europe

      Medical Dialogues Bureau19 Feb 2020 3:33 PM IST
      Abbott Park: Abbott has announced it has received CE Mark for the new Gallant™ implantable cardioverter-defibrillator (ICD) and cardiac...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok